D Gareth Evans Selected Research

Proteins (Proteins, Gene)

6/2023	Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.
1/2023	FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.
3/2022	Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.
1/2022	Breast cancer risks associated with missense variants in breast cancer susceptibility genes.
1/2022	Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers.
1/2021	Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
1/2019	Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma.
1/2019	The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.
1/2018	Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.
12/2014	Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D Gareth Evans Research Topics

Disease

87	Breast Neoplasms (Breast Cancer) 05/2024 - 05/2002
80	Neoplasms (Cancer) 03/2024 - 01/2004
22	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 02/2009
14	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2022 - 02/2016
12	Schwannomatosis 10/2023 - 03/2013
10	Acoustic Neuroma (Acoustic Neurinoma) 01/2023 - 02/2016
10	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2022 - 12/2008
9	Neurofibromatoses (Neurofibromatosis) 10/2023 - 01/2014
9	Neurofibromatosis 1 (Neurofibromatosis Type I) 10/2023 - 01/2015
9	Neurilemmoma (Schwannoma) 05/2023 - 02/2005
9	Prostatic Neoplasms (Prostate Cancer) 05/2023 - 10/2010
8	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 05/2011
7	Meningioma (Meningiomas) 05/2023 - 12/2014
6	Endometrial Neoplasms (Endometrial Cancer) 12/2023 - 01/2020
6	Genetic Predisposition to Disease (Genetic Predisposition) 11/2023 - 01/2012
5	Triple Negative Breast Neoplasms 01/2023 - 10/2013
4	Carcinoma (Carcinomatosis) 05/2024 - 12/2008
4	Ependymoma 05/2023 - 12/2012
3	Carcinogenesis 02/2024 - 12/2011
3	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2023 - 11/2020
3	Glioma (Gliomas) 11/2021 - 10/2020
3	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2013
3	Familial Breast Cancer 09/2014 - 10/2002
2	Adenoma (Adenomas) 05/2024 - 12/2008
2	Inflammation (Inflammations) 01/2023 - 01/2019
2	Melanoma (Melanoma, Malignant) 10/2022 - 11/2020
2	Obesity 12/2021 - 11/2015
2	Overweight 12/2021 - 01/2018
2	Neurofibrosarcoma (MPNST) 11/2021 - 01/2021
2	Fallopian Tube Neoplasms 05/2017 - 01/2013
1	Venous Thromboembolism 04/2024
1	Li-Fraumeni Syndrome 02/2024
1	Type 2 Diabetes Mellitus (MODY) 12/2023
1	Sarcoma (Soft Tissue Sarcoma) 11/2023
1	Ring Chromosomes (Ring Chromosome) 07/2023
1	Autism Spectrum Disorder 01/2023

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 06/2023 - 05/2002
17	Estrogen ReceptorsIBA 05/2023 - 10/2010
14	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2003
13	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2010
10	Hormones (Hormone)IBA 05/2024 - 10/2010
10	Bevacizumab (Avastin)FDA Link 05/2023 - 11/2014
9	Tamoxifen FDA LinkGeneric 12/2023 - 07/2003
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2023 - 12/2008
5	Progesterone Receptors (Progesterone Receptor)IBA 03/2022 - 01/2011
5	Uvitex SWN (SWN)IBA 01/2022 - 08/2016
4	Oral ContraceptivesIBA 12/2023 - 02/2009
4	Aromatase InhibitorsIBA 12/2023 - 07/2003
4	Anastrozole (Arimidex)FDA LinkGeneric 12/2023 - 09/2014
4	Resistant StarchIBA 01/2022 - 12/2008
3	Calcibiotic Root Canal SealerIBA 05/2024 - 01/2019
3	Testosterone (Sustanon)FDA Link 12/2023 - 05/2023
3	Phenobarbital (Luminal)FDA Link 12/2022 - 01/2020
3	NucleotidesIBA 11/2022 - 04/2015
3	human ERBB2 proteinIBA 01/2022 - 01/2019
3	Genetic Markers (Genetic Marker)IBA 01/2021 - 09/2014
3	Prostate-Specific Antigen (Semenogelase)IBA 12/2019 - 01/2018
3	Raloxifene Hydrochloride (Evista)FDA Link 01/2018 - 07/2003
2	mahuang-tangIBA 05/2024 - 05/2021
2	Phosphotransferases (Kinase)IBA 01/2023 - 05/2002
2	ORALIT (ORS)IBA 03/2022 - 01/2018
2	Progesterone FDA LinkGeneric 01/2022 - 01/2021
2	Estrogens (Estrogen)FDA Link 01/2022 - 01/2011
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2012
2	Neurofibromin 1 (Neurofibromin)IBA 10/2018 - 01/2017
2	Cadherins (E-Cadherin)IBA 01/2018 - 10/2013
2	RacivirIBA 05/2017 - 01/2013
2	RNA (Ribonucleic Acid)IBA 11/2016 - 09/2014
2	ParaffinIBA 12/2014 - 06/2012
2	Starch (Cornstarch)IBA 12/2011 - 12/2008
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2011 - 09/2008
2	Complementary DNA (cDNA)IBA 07/2006 - 02/2005
1	Metformin (Glucophage)FDA LinkGeneric 02/2024
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2023
1	Sex Hormone-Binding GlobulinIBA 12/2023
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 11/2023
1	Codon (Codons)IBA 11/2023
1	Aligeron (AS 2)IBA 07/2023
1	Dutasteride (Avodart)FDA Link 05/2023
1	AndrogensIBA 05/2023
1	Angiogenesis InhibitorsIBA 01/2023
1	Simvastatin (Zocor)FDA LinkGeneric 01/2023
1	BMS204352IBA 01/2023
1	ChemokinesIBA 01/2023
1	ubiquinone 6IBA 10/2022

Therapy/Procedure

18	Therapeutics 05/2024 - 07/2003
16	Salpingo-oophorectomy 11/2023 - 03/2008
13	Radiotherapy 11/2023 - 01/2014
10	Mastectomy (Mammectomy) 01/2022 - 09/2010
10	Ovariectomy (Oophorectomy) 01/2022 - 10/2002
8	Genomic Medicine 03/2024 - 01/2017
7	Drug Therapy (Chemotherapy) 01/2021 - 01/2004
6	Chemoprevention 04/2024 - 05/2010
6	Hormone Replacement Therapy (Therapy, Hormone Replacement) 12/2023 - 11/2005
4	Aftercare (After-Treatment) 01/2022 - 08/2015
3	Hysterectomy 12/2023 - 07/2020
2	Salpingectomy 01/2022 - 01/2021
1	Precision Medicine 10/2023
1	Immunotherapy 10/2023
1	Off-Label Use 01/2023